| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal
|
Kuruva, Chandra Sekhar
|
|
2017
|
22 |
2 |
p. 223-233
|
artikel
|
| 2 |
Are SAR tables obsolete?
|
Abad-Zapatero, Celerino
|
|
2017
|
22 |
2 |
p. 195-198
|
artikel
|
| 3 |
Bioimaging of nanoparticles: the crucial role of discriminating nanoparticles from free probes
|
Hu, Xiongwei
|
|
2017
|
22 |
2 |
p. 382-387
|
artikel
|
| 4 |
Contents page 1
|
|
|
2017
|
22 |
2 |
p. i
|
artikel
|
| 5 |
Contents page 2
|
|
|
2017
|
22 |
2 |
p. ii
|
artikel
|
| 6 |
Continuous manufacturing via hot-melt extrusion and scale up: regulatory matters
|
Maniruzzaman, Mohammed
|
|
2017
|
22 |
2 |
p. 340-351
|
artikel
|
| 7 |
Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery
|
Sharma, Ashok Kumar
|
|
2017
|
22 |
2 |
p. 314-326
|
artikel
|
| 8 |
Designed covalent allosteric modulators: an emerging paradigm in drug discovery
|
Lu, Shaoyong
|
|
2017
|
22 |
2 |
p. 447-453
|
artikel
|
| 9 |
Design of efficient computational workflows for in silico drug repurposing
|
Vanhaelen, Quentin
|
|
2017
|
22 |
2 |
p. 210-222
|
artikel
|
| 10 |
Downregulation of melanogenesis: drug discovery and therapeutic options
|
Pillaiyar, Thanigaimalai
|
|
2017
|
22 |
2 |
p. 282-298
|
artikel
|
| 11 |
Doxorubicin: nanotechnological overviews from bench to bedside
|
Cagel, Maximiliano
|
|
2017
|
22 |
2 |
p. 270-281
|
artikel
|
| 12 |
Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases
|
Geldenhuys, Werner J.
|
|
2017
|
22 |
2 |
p. 352-365
|
artikel
|
| 13 |
Fragmentation in the biopharmaceutical industry
|
Goldsmith, Andrew D.
|
|
2017
|
22 |
2 |
p. 433-439
|
artikel
|
| 14 |
Global vision of druggability issues: applications and perspectives
|
Abi Hussein, Hiba
|
|
2017
|
22 |
2 |
p. 404-415
|
artikel
|
| 15 |
Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation
|
Gentile, Eugenia
|
|
2017
|
22 |
2 |
p. 299-313
|
artikel
|
| 16 |
Mimicking the ocular environment for the study of inflammatory posterior eye disorders
|
Dulull, Nabeela K.
|
|
2017
|
22 |
2 |
p. 440-446
|
artikel
|
| 17 |
miRNA nanotherapeutics for cancer
|
Ganju, Aditya
|
|
2017
|
22 |
2 |
p. 424-432
|
artikel
|
| 18 |
Molecular dynamics-driven drug discovery: leaping forward with confidence
|
Ganesan, Aravindhan
|
|
2017
|
22 |
2 |
p. 249-269
|
artikel
|
| 19 |
Molecular similarity considerations in the licensing of orphan drugs
|
Franco, Pedro
|
|
2017
|
22 |
2 |
p. 377-381
|
artikel
|
| 20 |
New concepts in asthma: clinical phenotypes and pathophysiological mechanisms
|
Koczulla, Andreas R.
|
|
2017
|
22 |
2 |
p. 388-396
|
artikel
|
| 21 |
Organs-on-chips: research and commercial perspectives
|
Balijepalli, Aarathi
|
|
2017
|
22 |
2 |
p. 397-403
|
artikel
|
| 22 |
Peptidomimetic therapeutics: scientific approaches and opportunities
|
Qvit, Nir
|
|
2017
|
22 |
2 |
p. 454-462
|
artikel
|
| 23 |
Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism
|
Isvoran, Adriana
|
|
2017
|
22 |
2 |
p. 366-376
|
artikel
|
| 24 |
Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins
|
Radhakrishnan, Krishna
|
|
2017
|
22 |
2 |
p. 416-423
|
artikel
|
| 25 |
Semiconductor technology in protein kinase research and drug discovery: sensing a revolution
|
Bhalla, Nikhil
|
|
2017
|
22 |
2 |
p. 204-209
|
artikel
|
| 26 |
The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts
|
da Cunha, Nicolau B.
|
|
2017
|
22 |
2 |
p. 234-248
|
artikel
|
| 27 |
The SULSA Assay Development Fund: accelerating translation of new biology from academia to pharma
|
McElroy, Stuart P.
|
|
2017
|
22 |
2 |
p. 199-203
|
artikel
|
| 28 |
The unique status of first-in-human studies: strengthening the social value requirement
|
Habets, Michelle G.J.L.
|
|
2017
|
22 |
2 |
p. 471-475
|
artikel
|
| 29 |
Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations
|
Langley, Gillian R.
|
|
2017
|
22 |
2 |
p. 327-339
|
artikel
|
| 30 |
UPLC–MS for metabolomics: a giant step forward in support of pharmaceutical research
|
Nassar, Ala F.
|
|
2017
|
22 |
2 |
p. 463-470
|
artikel
|
Tijdschrift beschrijving